Literature DB >> 9882294

Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses.

U Bantel-Schaal1, H Delius, R Schmidt, H zur Hausen.   

Abstract

We have characterized 95% (4,404 nucleotides) of the genome of adeno-associated virus type 5 (AAV5), including part of the terminal repeats and the terminal resolution site. Our results show that AAV5 is different from all other described AAV serotypes at the nucleotide level and at the amino acid level. The sequence homology to AAV2, AAV3B, AAV4, and AAV6 at the nucleotide level is only between 54 and 56%. The positive strand contains two large open reading frames (ORFs). The left ORF encodes the nonstructural (Rep) proteins, and the right ORF encodes the structural (Cap) proteins. At the amino acid level the identities with the capsid proteins of other AAVs range between 51 and 59%, with a high degree of heterogeneity in regions which are considered to be on the exterior surface of the viral capsid. The overall identity for the nonstructural Rep proteins at the amino acid level is 54.4%. It is lowest at the C-terminal 128 amino acids (10%). There are only two instead of the common three putative Zn fingers in the Rep proteins. The Cap protein data suggest differences in capsid surfaces and raise the possibility of a host range distinct from those of other parvoviruses. This may have important implications for AAV vectors used in gene therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882294      PMCID: PMC103913     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein.

Authors:  Y Shi; E Seto; L S Chang; T Shenk
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  TRANSFAC, TRRD and COMPEL: towards a federated database system on transcriptional regulation.

Authors:  E Wingender; A E Kel; O V Kel; H Karas; T Heinemeyer; P Dietze; R Knüppel; A G Romaschenko; N A Kolchanov
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

Review 3.  Parvovirus gene regulation.

Authors:  K I Berns; M A Labow
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

4.  The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification.

Authors:  R Heilbronn; A Bürkle; S Stephan; H zur Hausen
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

Authors:  S Muramatsu; H Mizukami; N S Young; K E Brown
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

6.  Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

Authors:  E A Rutledge; C L Halbert; D W Russell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels.

Authors:  S R Kyöstiö; R A Owens; M D Weitzman; B A Antoni; N Chejanovsky; B J Carter
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells.

Authors:  L A Hunter; R J Samulski
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  The adeno-associated virus Rep78 protein is covalently linked to viral DNA in a preformed virion.

Authors:  K M Prasad; J P Trempe
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

10.  Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus.

Authors:  P F Su; F Y Wu
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more
  34 in total

Review 1.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

2.  Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses.

Authors:  Jianming Qiu; Ramnath Nayak; Gregory E Tullis; David J Pintel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing.

Authors:  Tyler Janovitz; Thiago Oliveira; Michel Sadelain; Erik Falck-Pedersen
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

4.  Upstream AP1- and CREB-binding sites confer high basal activity on the adeno-associated virus type 5 capsid gene promoter.

Authors:  Chaoyang Ye; David J Pintel
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

5.  Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

Authors:  N Kaludov; K E Brown; R W Walters; J Zabner; J A Chiorini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.

Authors:  Dawn E Bowles; Joseph E Rabinowitz; R Jude Samulski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Complete DNA sequence of the rat cytomegalovirus genome.

Authors:  C Vink; E Beuken; C A Bruggeman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.

Authors:  D Duan; Z Yan; Y Yue; W Ding; J F Engelhardt
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

10.  Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice.

Authors:  Jianping Lin; Yan Zhi; Lauren Mays; James M Wilson
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.